PT Diagnos Laboratorium Utama Tbk DGNS.JK Stock
PT Diagnos Laboratorium Utama Tbk Price Chart
PT Diagnos Laboratorium Utama Tbk DGNS.JK Financial and Trading Overview
| PT Diagnos Laboratorium Utama Tbk stock price | 314 IDR |
| Previous Close | 199 IDR |
| Open | 199 IDR |
| Bid | 196 IDR x N/A |
| Ask | 198 IDR x N/A |
| Day's Range | 194 - 200 IDR |
| 52 Week Range | 190 - 440 IDR |
| Volume | 114.3K IDR |
| Avg. Volume | 452.52K IDR |
| Market Cap | 248.75B IDR |
| Beta (5Y Monthly) | 0.822763 |
| PE Ratio (TTM) | 3.8385866 |
| EPS (TTM) | 51.84 IDR |
| Forward Dividend & Yield | 4.8 (1.55%) |
| Ex-Dividend Date | August 6, 2021 |
| 1y Target Est | N/A |
DGNS.JK Valuation Measures
| Enterprise Value | 250.17B IDR |
| Trailing P/E | 3.8385866 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4409084 |
| Price/Book (mrq) | 1.2019085 |
| Enterprise Value/Revenue | 1.449 |
| Enterprise Value/EBITDA | 22.817 |
Trading Information
PT Diagnos Laboratorium Utama Tbk Stock Price History
| Beta (5Y Monthly) | 0.822763 |
| 52-Week Change | -34.10% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 440 IDR |
| 52 Week Low | 190 IDR |
| 50-Day Moving Average | 215.66 IDR |
| 200-Day Moving Average | 245.9 IDR |
DGNS.JK Share Statistics
| Avg. Volume (3 month) | 452.52K IDR |
| Avg. Daily Volume (10-Days) | 366.69K IDR |
| Shares Outstanding | 1.25B |
| Float | 249.5M |
| Short Ratio | N/A |
| % Held by Insiders | 80.04% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0.46% |
| Operating Margin (ttm) | 0.57% |
| Gross Margin | 46.28% |
| EBITDA Margin | 6.35% |
Management Effectiveness
| Return on Assets (ttm) | 0.24% |
| Return on Equity (ttm) | 0.38% |
Income Statement
| Revenue (ttm) | 172.63B IDR |
| Revenue Per Share (ttm) | 138.11 IDR |
| Quarterly Revenue Growth (yoy) | -35.00000000000000000000000000000000% |
| Gross Profit (ttm) | 93.76B IDR |
| EBITDA | 10.96B IDR |
| Net Income Avi to Common (ttm) | 798.75M IDR |
| Diluted EPS (ttm) | 51.842 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.61B IDR |
| Total Cash Per Share (mrq) | 19.69 IDR |
| Total Debt (mrq) | 27.27B IDR |
| Total Debt/Equity (mrq) | 13.18 IDR |
| Current Ratio (mrq) | 7.957 |
| Book Value Per Share (mrq) | 165.57 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.34B IDR |
| Levered Free Cash Flow (ttm) | -30318499840 IDR |
Profile of PT Diagnos Laboratorium Utama Tbk
| Country | Indonesia |
| State | N/A |
| City | Jakarta Pusat |
| Address | Gedung Graha Anam Lantai 2 |
| ZIP | 10350 |
| Phone | 62 21 3193 1833 |
| Website | https://diagnos.co.id |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 54 |
PT Diagnos Laboratorium Utama Tbk provides health services using laboratories in Indonesia. The company offers clinical pathology laboratory tests comprising hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology; and genomics laboratory tests that provides genetic testing for reproductive health, pregnant women, couples who want to have a child, oncology tests, drug sensitivity, DNAandMe, and others. It also offers homecare health services for hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C; and SARS-CoV-2 screening services. The company was founded in 2007 and is headquartered in Jakarta Pusat, Indonesia.
Q&A For PT Diagnos Laboratorium Utama Tbk Stock
What is a current DGNS.JK stock price?
PT Diagnos Laboratorium Utama Tbk DGNS.JK stock price today per share is 314 IDR.
How to purchase PT Diagnos Laboratorium Utama Tbk stock?
You can buy DGNS.JK shares on the Jakarta exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PT Diagnos Laboratorium Utama Tbk?
The stock symbol or ticker of PT Diagnos Laboratorium Utama Tbk is DGNS.JK.
Which industry does the PT Diagnos Laboratorium Utama Tbk company belong to?
The PT Diagnos Laboratorium Utama Tbk industry is Diagnostics & Research.
How many shares does PT Diagnos Laboratorium Utama Tbk have in circulation?
The max supply of PT Diagnos Laboratorium Utama Tbk shares is 1.25B.
What is PT Diagnos Laboratorium Utama Tbk Price to Earnings Ratio (PE Ratio)?
PT Diagnos Laboratorium Utama Tbk PE Ratio is 6.05686500 now.
What was PT Diagnos Laboratorium Utama Tbk earnings per share over the trailing 12 months (TTM)?
PT Diagnos Laboratorium Utama Tbk EPS is 51.84 IDR over the trailing 12 months.
Which sector does the PT Diagnos Laboratorium Utama Tbk company belong to?
The PT Diagnos Laboratorium Utama Tbk sector is Healthcare.
PT Diagnos Laboratorium Utama Tbk DGNS.JK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| IDX COMPOSITE JKSE | 7286.88 IDR 0.47 USD |
+0.45
|
— — | 7239.27 IDR 0.46 USD | 7298.86 IDR 0.47 USD | — - | — — |
- {{ link.label }} {{link}}